DEAN SLAGEL

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cara Therapeutics, Inc.

Filing Date Source Excerpt
2015-04-24 Mr. Slagel is the Managing Director of Esperante BV and Esperante AB, life sciences venture investment companies. He received an MBA from the ENPC Business School in Paris, France.
2016-04-27 Mr. Slagel is the Managing Director of Esperante BV and Esperante AB, life sciences venture investment companies... He received an MBA from the ENPC Business School in Paris, France, in 2000.
2017-05-10 Mr. Slagel is the Managing Director of Esperante BV and Esperante AB, life sciences venture investment companies founded in September 2004 and June 2005, respectively. From September 1995 to September 2004, Mr. Slagel served as the Global Business Development Director of Ferring Pharmaceuticals.

Data sourced from SEC filings. Last updated: 2026-03-09